Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDSenti Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
| Q4 2024 | 1 | -$3.13 | -$3.13 | -$3.13 |
Senti Biosciences, Inc. Earnings Date And Information
Senti Biosciences, Inc. last posted its earnings results on Thursday, May 9th, 2024. The company reported $-2.6 earnings per share for the quarter, missing analysts' consensus estimates of $-0.23 by $2.37. The company had revenue of 0 for the quarter and had revenue of 2.56 M for the year. Senti Biosciences, Inc. has generated $-16 earnings per share over the last year ($-16.01 diluted earnings per share) and currently has a price-to-earnings ratio of -0.26. Senti Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based on prior year's report dates.
Senti Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$6.31 | $0 | $0 | ||
| 08/13/2024 | Q2 2024 | -$2.45 | $0 | $0 | ||
| 05/09/2024 | Q1 2024 | -$0.23 | -$2.65 | -2.42 | $0 | |
| 04/26/2024 | Q4 2023 | -$0.42 | $333,000 | |||
| 11/13/2023 | Q3 2023 | -$3.36 | $668,500 | $255,000 | ||
| 08/11/2023 | Q2 2023 | -$4.80 | -$4.22 | 0.58 | $500,000 | $937,000 |
| 05/09/2023 | Q1 2023 | -$4.80 | -$4.25 | 0.55 | $1.04 M | |
| 03/22/2023 | Q4 2022 | -$4.70 | -$4.16 | 0.54 | $59,000 | |
| 11/10/2022 | Q3 2022 | -$5.20 | -$0.38 | 4.82 | $929,000 | $1.77 M |
| 08/15/2022 | Q2 2022 | -$0.86 | $1.11 M | |||
| 05/16/2022 | Q1 2022 | -$0.27 | $854,000 | |||
| 03/07/2022 | Q4 2021 | -$0.25 | $543,000 | |||
| 11/10/2021 | Q3 2021 | -$0.26 | $926,000 | |||
| 08/06/2021 | Q2 2021 | -$0.28 | $778,000 | |||
| 07/02/2021 | Q1 2021 | $0.00 | $72,000 | |||
| 12/30/2020 | Q4 2020 | -$0.07 | $2,000 |
Senti Biosciences, Inc. Earnings: FAQ's
When is Senti Biosciences, Inc.'s earnings date?
Senti Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates.
How can I listen to Senti Biosciences, Inc.'s earnings conference
call?
The conference call for Senti Biosciences, Inc.'s latest earnings report can be listened to online.
How can I read Senti Biosciences, Inc.'s conference call transcript?
The conference call transcript for Senti Biosciences, Inc.'s latest earnings report can be read online.
How much revenue does Senti Biosciences, Inc. generate each year?
Senti Biosciences, Inc. (:SNTI) has a recorded annual revenue of $2.56 M.
How much profit does Senti Biosciences, Inc. generate each year?
Senti Biosciences, Inc. (:SNTI) has a recorded net income of $2.56 M. Senti Biosciences, Inc. has generated $-16.01 earnings per share over the last four quarters.
What is Senti Biosciences, Inc.'s price-to-earnings ratio?
Senti Biosciences, Inc. (:SNTI) has a price-to-earnings ratio of -0.26 and price/earnings-to-growth ratio is 0.01.